Form 4: Kura Oncology COO Kathleen Ford Acquires Shares Through Employee Stock Purchase Plan

Kura Oncology's Chief Operating Officer, Kathleen Ford, acquired 526 shares of common stock through the company's Employee Stock Purchase Plan.

Summary

• Kathleen Ford, Chief Operating Officer of Kura Oncology, acquired 526 shares of common stock on November 18, 2024.
• The shares were purchased through the company's Employee Stock Purchase Plan.
• The transaction was executed at a weighted average price of $16.0337 per share, with individual trades ranging from $15.78 to $16.25.
• Following this transaction, Ms. Ford beneficially owns 23,184 shares of Kura Oncology common stock.
• This includes 1,582 shares acquired on May 17, 2024, also through the Employee Stock Purchase Plan.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction, which is generally positive as it indicates employee participation in the company's growth. There is no indication of any negative sentiment.

Positives

• The purchase of shares by a company executive can be seen as a positive sign of confidence in the company's future.
• The Employee Stock Purchase Plan allows employees to invest in the company at potentially favorable terms.

Industry Context

This is a routine transaction related to employee compensation and is common in publicly traded companies.

Comparison to Industry Standards

• Employee stock purchase plans are a common practice in the biotechnology industry, used to incentivize and retain employees.
• The transaction is consistent with standard practices for executive stock ownership and reporting requirements.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it indicates executive confidence in the company.
• Employees benefit from the Employee Stock Purchase Plan.

Key Dates

Keywords

Kura Oncology, Employee Stock Purchase Plan, Kathleen Ford, stock acquisition, insider trading, Form 4, COO